SAMANTHA ROSSI: Open Payments
NPI 1104474162 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 21 payments from 10 companies in 2025. Trend: 2023 $393 · 2024 $637 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 8 | $162 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| GENZYME CORPORATION | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Pharming Healthcare, Inc. | 1 | $20 |
| JAZZ PHARMACEUTICALS INC. | 1 | $19 |
| Optinose US, Inc. | 1 | $15 |
Products named: Hizentra, NEFFY, DUPIXENT, NUCALA, Sunosi, TAKHZYRO, Andembry, RUCONEST.
Industry payments across NY — which companies pay providers there.
